Incidence, prevalence and mortality of bullous pemphigoid in England 1998–2017: a population‐based cohort study von Persson, M.S.M., Harman, K.E., Vinogradova, Y., Langan, S.M., Hippisley‐Cox, J., Thomas, K.S., Gran, S.

Volltext

The global incidence of bullous pemphigoid: a systematic review and meta‐analysis von Persson, M.S.M., Begum, N., Grainge, M.J., Harman, K.E., Grindlay, D., Gran, S.

Volltext

Cause‐specific mortality in people with bullous pemphigoid and pemphigus vulgaris: a systematic review and meta‐analysis von Hasanaj, A., Zaki, F., Harman, K.E., Grindlay, D., Gran, S.

Volltext

Using electronic health records to inform trial feasibility in a rare autoimmune blistering skin disease in England von Persson, M. S. M., Harman, K. E., Thomas, K. S., Chalmers, J. R., Vinogradova, Y., Langan, S. M., Hippisley-Cox, J., Gran, S.

Volltext

Rituximab with prednisolone as first‐line treatment in pemphigus vulgaris von Scorer, M., Setterfield, J.F., Harman, K.E.

Volltext

Generating new evidence, improving clinical practice and developing research capacity: the benefits of recruiting to the U.K. Dermatology Clinical Trials Network's STOP GAP and BLI... von Batchelor, J.M., Chapman, A., Craig, F.E., Harman, K.E., Kirtschig, G., Martin‐Clavijo, A., Ormerod, A.D., Walton, S., Williams, H.C.

Volltext

A successful therapeutic trial of rituximab in the treatment of a patient with recalcitrant, high-titre epidermolysis bullosa acquisita von Crichlow, S.M., Mortimer, N.J., Harman, K.E.

Volltext

High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases von Harman, K E, Black, M M

Volltext

Alopecia universalis‐like hair loss in acrodermatitis enteropathica von Shah, A., Veitch, D., Harman, K. E.

Volltext

Orf – a potential trigger for self‐limiting epidermolysis bullosa acquisita‐like blistering von Carmichael, A.J., Harman, K.E.

Volltext

An evaluation of the usefulness of mycophenolate mofetil in pemphigus von Powell, A.M., Albert, S., Al Fares, S., Harman, K.E., Setterfield, J., Bhogal, B., Black, M.M.

Volltext

Toxic epidermal necrolysis‐like lupus von Roberts, E. J., Melchionda, V., Saldanha, G., Shaffu, S., Royle, J., Harman, K. E.

Volltext

Is IgA antineutrophil cytoplasmic antibody a marker for patients with erythema elevatum diutinum? A further three cases demonstrating this association von Crichlow, S.M., Alexandroff, A.B., Simpson, R.C., Saldanha, G., Walker, S., Harman, K.E.

Volltext

What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 2: Epidemiology, aetiology and risk factors von Lloyd‐Lavery, A., Solman, L., Grindlay, D. J. C., Rogers, N. K., Thomas, K. S., Harman, K. E.

Volltext

What’s new in atopic eczema? An analysis of systematic reviews published in 2018. Part 1: prevention and topical therapies von Tasker, F., Brown, A., Grindlay, D. J. C., Rogers, N. K., Harman, K. E.

Volltext

What’s new in atopic eczema? An analysis of systematic reviews published in 2018. Part 2: systemic therapies von Olabi, B., Worboys, S., Garland, T., Grindlay, D. J. C., Rogers, N. K., Harman, K. E.

Volltext

Evidence of an association between desmoglein 3 haplotypes and pemphigus vulgaris von Capon, F., Bharkhada, J., Cochrane, N.E., Mortimer, N.J., Setterfield, J.F., Reynaert, S., Black, M.M., Vaughan, R.W., Trembath, R.C., Harman, K.E.

Volltext

Doxycycline-induced hypoglycaemia von Tan, C. H., Shelley, C., Harman, K. E.

Volltext

Persistent anticonvulsant hypersensitivity syndrome responding to ciclosporin von Harman, K. E., Morris, S. D., Higgins, E. M.

Volltext

What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 3: nomenclature and outcome assessment von Lloyd‐Lavery, A., Solman, L., Grindlay, D. J. C., Rogers, N. K., Thomas, K. S., Harman, K. E.

Volltext